Literature DB >> 34228549

Tigecycline-Induced Tooth Discoloration in Children Younger than Eight Years.

Zhengyi Zhu1, Qi Yu2, Ganggang Qi2, Jufei Yang1, Yinghua Ni1, Wenhua Ruan3, Luo Fang4.   

Abstract

Tetracycline may cause tooth discoloration when used in young children during tooth development. Whether tigecycline, a tetracycline derivative, has either a similar adverse event or not remains unclear. We assessed the discoloration of the permanent teeth of patients <8 years old after tigecycline exposure. These patients were identified through a retrospective chart review in a Chinese children's hospital. Those who had at least one erupted permanent tooth after tigecycline exposure were interviewed, examined, and photographed by an experienced pediatric dentist and independently assessed by another senior dentist to detect tetracycline-like tooth discoloration. We identified 101 patients who were exposed to tigecycline, 12 of whom were included. The mean daily dose of tigecycline was 2.3 mg/kg of body weight (standard deviation, 0.6), and the median duration was 12.5 days (interquartile range [IQR], 8.0 to 19.3). The median age of exposure was 5.2 years (IQR, 4.5 to 7.4), and the median age of dental examination was 9.1 years (IQR, 9.0 to 10.3). Two patients (16.7%) developed yellow discoloration: a girl having yellow discoloration with white-to-yellow opacities in the upper lateral incisors and lower incisors and a boy with a suspicious buccal yellow discoloration and enamel dysplasia in the second molars. The incidence and extent of tigecycline-associated dental adverse events remain unclear due to the small sample size and inadequate follow-up period.

Entities:  

Keywords:  adverse event; children; tigecycline; tooth discoloration

Mesh:

Substances:

Year:  2021        PMID: 34228549      PMCID: PMC8370207          DOI: 10.1128/AAC.00854-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  No findings of dental defects in children treated with minocycline.

Authors:  Antonio Cascio; Chiara Di Liberto; Matteo D'Angelo; Chiara Iaria; Francesco Scarlata; Lucina Titone; Giuseppina Campisi
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

2.  Absence of tooth staining with doxycycline treatment in young children.

Authors:  Benjamin Volovitz; Ronit Shkap; Jacob Amir; Shlomo Calderon; Izhak Varsano; Moshe Nussinovitch
Journal:  Clin Pediatr (Phila)       Date:  2007-03       Impact factor: 1.168

3.  Doxycycline and staining of permanent teeth.

Authors:  M E Lochary; P B Lockhart; W T Williams
Journal:  Pediatr Infect Dis J       Date:  1998-05       Impact factor: 2.129

4.  Preliminary experience of tigecycline treatment for infection in children with hematologic malignancies.

Authors:  Shupeng Lin; Chenmei Zhang; Sheng Ye
Journal:  Int J Clin Pharm       Date:  2018-07-26

Review 5.  Teeth.

Authors:  Ronald J Billings; Robert J Berkowitz; Gene Watson
Journal:  Pediatrics       Date:  2004-04       Impact factor: 7.124

6.  Preliminary experience with tigecycline treatment for severe infection in children.

Authors:  Sheng Ye; Chenmei Zhang; Shupeng Lin
Journal:  Eur J Pediatr       Date:  2018-07-14       Impact factor: 3.183

7.  Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016).

Authors:  Michael A Pfaller; Michael D Huband; Jennifer M Streit; Robert K Flamm; Helio S Sader
Journal:  Int J Antimicrob Agents       Date:  2018-02-02       Impact factor: 5.283

8.  Dental staining after doxycycline use in children.

Authors:  Heidi Pöyhönen; Mirka Nurmi; Ville Peltola; Satu Alaluusua; Olli Ruuskanen; Tuire Lähdesmäki
Journal:  J Antimicrob Chemother       Date:  2017-10-01       Impact factor: 5.790

9.  Tigecycline application in a 3-month-old infant with multiple drug resistant Klebsiella pneumonia: a case report.

Authors:  Cheng Peng; Xiaofeng Wang; Jiangwei Zhang; Yi Jiang; Xinlin Hou
Journal:  Gut Pathog       Date:  2018-06-22       Impact factor: 4.181

10.  Preliminary experience of tigecycline treatment in critically ill children with ventilator-associated pneumonia.

Authors:  Shupeng Lin; Lingfang Liang; Chenmei Zhang; Sheng Ye
Journal:  J Int Med Res       Date:  2018-04-03       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.